Tilray | Renteudgifter På Gæld



Interest Expense On Debt Lave om Dato
Acasti Pharma USD 0 0 2021-06
Alaunos Therapeutics USD 0 0 2023-12
Aurora Cannabis CAD 1.29M 768K 2024-12
Avita Medical AUD 1.35M 230K 2024-06
Canopy Growth CAD 16.77M 4.51M 2024-12
Cronos Group USD 0 7K 2024-09
Dianthus Therapeutics 4.44M 4.44M 2024-09
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
IQVIA Holdings USD 171M 1000K 2024-12
Knight Therapeutics CAD 1.91M 369K 2024-09
Moderna USD 6M 0 2024-12
Organon & Co USD 132M 6M 2024-12
Revvity USD 22.78M 1.6M 2024-12
Tectonic Therapeutic USD 25K 321K 2024-09
Tilray USD 7.77M 2.08M 2024-11
Viatris USD 120.2M 25.4M 2024-12
Xeris Pharmaceuticals USD 7.7M 83K 2024-12



Tilray Renteudgifter På Gæld - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.